Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Autoimmunity

Effectiveness of treatments for pregnant women with APS

The combination of heparin and aspirin is widely regarded as 'standard therapy' to increase rates of live birth in patients with recurrent pregnancy loss and positive antiphospholipid antibodies. However, this recommendation is based largely on expert opinion. Does a meta-analysis of randomized controlled trials support the practice?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mak, A., Cheung, M. W., Cheak, A. A. & Ho, R. C. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford) 49, 281–288 (2010).

    Article  CAS  Google Scholar 

  2. Levine, J. S., Branch, D. W. & Rauch, J. The antiphospholipid syndrome. N. Engl. J. Med. 346, 752–763 (2002).

    Article  CAS  Google Scholar 

  3. Empson, M., Lassere, M., Craig, J. & Scott, J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews. Issue 2. Art. No.: CD002859. doi:10.1002/14651858.CD002859.pub2 (2005).

    Google Scholar 

  4. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). Int. J. Gynaecol. Obstet. 78, 179–190 (2002).

  5. Miyakis, S. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4, 295–306 (2006).

    Article  CAS  Google Scholar 

  6. Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S. & Hirsh, J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (Suppl.), S844–S886 (2008).

    Article  Google Scholar 

  7. Girardi, G., Redecha, P. & Salmon, J. E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat. Med. 10, 1222–1226 (2004).

    Article  CAS  Google Scholar 

  8. White, N. J., McGready, R. M. & Nosten, F. H. New medicines for tropical diseases in pregnancy: catch-22. PLoS Med. 5, e133 (2008).

    Article  Google Scholar 

  9. Chervenak, F. A. & McCullough, L. B. Ethics of research in perinatal medicine. Semin. Perinatol. 33, 391–396 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jane E. Salmon.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gelber, S., Salmon, J. Effectiveness of treatments for pregnant women with APS. Nat Rev Rheumatol 6, 187–189 (2010). https://doi.org/10.1038/nrrheum.2010.42

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2010.42

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing